ASTROCYTOMA, GRADE III
Clinical trials for ASTROCYTOMA, GRADE III explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE III trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young brain cancer patients: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests whether adding the drug olutasidenib to standard chemotherapy (temozolomide) can help children and young adults with a specific type of brain cancer (IDH1-mutant high-grade glioma) live longer. About 60 participants will receive the combination as maintenance the…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for brain cancer patients: experimental combo enters trials
Disease control Recruiting nowThis study tests a new drug (Debio 0123) combined with standard chemotherapy (temozolomide) and sometimes radiation in adults with glioblastoma, an aggressive brain cancer. The goal is to find the safest dose and see if the combination helps people live longer. About 116 particip…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1, PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Gene therapy takes on deadly brain tumors in new trial
Disease control Recruiting nowThis study tests a gene therapy (HSV-tk) plus valacyclovir, along with radiation and chemotherapy, in people whose glioblastoma or high-grade astrocytoma has returned. The goal is to see if this combination can improve survival. About 62 participants will receive the treatment di…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1, PHASE2 • Sponsor: David Baskin MD • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC